Assyro AI

Orange Book product · Brand (NDA)

EMEND

APREPITANT

Brand (NDA)NDA 207865RX MSD MERCK CO

At a glance

Dec 17, 2015

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 17, 2015

    10 yr 8 mo ago

  2. Today

  3. Patent 8258132 expires

    Listed drug product patent expiration.

    Sep 26, 2027

    in 1 yr 3 mo

Pharmaceutical detail

Active ingredient

APREPITANT

Strength

125MG/KIT

Dosage form

FOR SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 207865

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8258132Sep 26, 2027in 1 yr 3 mo
ProductU-1916
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.